Case Study: Concept Life Sciences achieves more consistent, physiologically relevant neurological disease assays with bit.bio ioMicroglia

A bit.bio Case Study

Preview of the Concept Life Sciences Case Study

Concept Life Sciences improves assay consistency with bit.bio’s lot-to-lot stable ioMicroglia

Concept Life Sciences, a leading contract research organization, sought to develop more reliable and consistent long-term in vitro assays for neurological disease drug development. Their challenge was creating physiologically relevant models using human microglia, a process that had been inconsistent with primary cell lines and other human induced pluripotent stem cell (hiPSC)-derived cells.

bit.bio provided a solution with their ioMicroglia product, which offered highly functional cells with low inter-lot variability. This ensured consistent assay performance and facilitated large-scale screening studies. With support from the bit.bio team to integrate the cells into their workflows, Concept Life Sciences can now offer more human-relevant models to their clients, better supporting CNS-targeted drug development.


View this case study…

bit.bio

6 Case Studies